[Proton pump inhibitors in peptic ulcer bleeding].
Treatment with proton pump inhibitors (PPI) is shown to improve the outcome of peptic ulcer bleeding (PUB). A recent Cochrane review evaluated different regimes of PPI-treatment in the management of PUB. The current evidence suggests that treatment with high-dose PPI (cumulative PPI-dose > 600 mg for the first 72 hours) is not associated with an improved outcome compared to treatment with a lower dose of PPI. The available studies are, however, characterized by high risk of bias, insufficient blinding, and a low event rate. Therefore, the existing data are insufficient to conclude that lower doses of PPI are equally efficacious to high-dose treatment. As the current evidence is strongest for high-dose treatment for patients with serious PUB it is recommended to use high-dose PPI treatment in patients treated with endoscopic therapy. This is in line with the national recommendations in Denmark.